The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis
暂无分享,去创建一个
[1] D. Cordes,et al. Brain Entropy During Aging Through a Free Energy Principle Approach , 2021, Frontiers in Human Neuroscience.
[2] A. Pillai,et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease , 2021, Alzheimer's research & therapy.
[3] Robert A. Harris,et al. Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[4] Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease , 2020, Molecular Neurodegeneration.
[5] M. Michaelis,et al. Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[6] Bin Zhang,et al. Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation , 2019, bioRxiv.
[7] S. Black,et al. Preventing dementia by preventing stroke: The Berlin Manifesto , 2019, Alzheimer's & Dementia.
[8] J. Ko,et al. Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease , 2019, Neurobiology of Disease.
[9] R. Graham,et al. PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease , 2019, The Journal of Neuroscience.
[10] R. Paolicelli,et al. Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration , 2019, Front. Cell. Neurosci..
[11] M. Z. Cader,et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease , 2019, Nature Neuroscience.
[12] J. Bertran-Gonzalez,et al. Disease‐associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria , 2018, The EMBO journal.
[13] S. An,et al. Mitochondrial therapeutic interventions in Alzheimer’s disease , 2018, Journal of the Neurological Sciences.
[14] D. Blackburn,et al. Ursodeoxycholic Acid Improves Mitochondrial Function and Redistributes Drp1 in Fibroblasts from Patients with Either Sporadic or Familial Alzheimer's Disease , 2018, Journal of molecular biology.
[15] R. Rizzuto,et al. Tau localises within mitochondrial sub-compartments and its caspase cleavage affects ER-mitochondria interactions and cellular Ca2+ handling. , 2018, Biochimica et biophysica acta. Molecular basis of disease.
[16] Colin Smith,et al. Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease , 2018, Acta Neuropathologica.
[17] M. Pérez,et al. Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration , 2018, Front. Neurosci..
[18] Yi Su,et al. Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease , 2018, Neurobiology of Aging.
[19] G. Juhász,et al. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer’s Disease , 2018, Molecular Neurobiology.
[20] F. Kametani,et al. Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease , 2018, Front. Neurosci..
[21] M. Shamloo,et al. Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease , 2017, Oncotarget.
[22] A. McKee,et al. SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease , 2017, Aging cell.
[23] E. Schon,et al. A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease , 2018, Cell Death & Disease.
[24] L. Lue,et al. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer’s disease , 2017, Brain : a journal of neurology.
[25] P. Mecocci,et al. Of Energy and Entropy: The Ineluctable Impact of Aging in Old Age Dementia , 2017, International journal of molecular sciences.
[26] Z. Khachaturian,et al. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis , 2017, Alzheimer's & Dementia.
[27] Ramesh Kandimalla,et al. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease. , 2016, Human molecular genetics.
[28] Nazanin Mirzaei,et al. PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model , 2016, Proceedings of the National Academy of Sciences.
[29] G. Bu,et al. Modulation of Mitochondrial Complex I Activity Averts Cognitive Decline in Multiple Animal Models of Familial Alzheimer's Disease , 2015, EBioMedicine.
[30] R. Swerdlow,et al. The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. , 2014, Biochimica et biophysica acta.
[31] G. Pasinetti,et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models , 2013, Neurobiology of Aging.
[32] F. Gunn-Moore,et al. Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease? , 2013, Current Alzheimer research.
[33] D. Attwell,et al. Synaptic Energy Use and Supply , 2012, Neuron.
[34] M. Feany,et al. Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo , 2012, Neuron.
[35] C. Cotman,et al. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. , 2012, Archives of neurology.
[36] I. Bezprozvanny,et al. The dysregulation of intracellular calcium in Alzheimer disease. , 2010, Cell calcium.
[37] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[38] D. Chan. Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.
[39] Xi Chen,et al. Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .
[40] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[41] M. Beal,et al. Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease , 1994, Journal of neurochemistry.